| 摘要 |
A stable pharmaceutically acceptable aqueous formulation containing human growth hormone linked to an extended recombinant polypeptide (XTEN) and a buffer is disclosed, wherein the formulation is lacking a surfactant. Also disclosed are associated methods for preparing, storing, and using such formulations. |
